161 related articles for article (PubMed ID: 9927037)
1. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas.
Park WS; Dong SM; Kim SY; Na EY; Shin MS; Pi JH; Kim BJ; Bae JH; Hong YK; Lee KS; Lee SH; Yoo NJ; Jang JJ; Pack S; Zhuang Z; Schmidt L; Zbar B; Lee JY
Cancer Res; 1999 Jan; 59(2):307-10. PubMed ID: 9927037
[TBL] [Abstract][Full Text] [Related]
2. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
[TBL] [Abstract][Full Text] [Related]
3. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.
Lorenzato A; Olivero M; Patanè S; Rosso E; Oliaro A; Comoglio PM; Di Renzo MF
Cancer Res; 2002 Dec; 62(23):7025-30. PubMed ID: 12460923
[TBL] [Abstract][Full Text] [Related]
4. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
5. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
6. Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients.
Salvi A; Marchina E; Benetti A; Grigolato P; De Petro G; Barlati S
Int J Oncol; 2008 Aug; 33(2):271-6. PubMed ID: 18636147
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
Wang XH; Wang PL
Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.
Daveau M; Scotte M; François A; Coulouarn C; Ros G; Tallet Y; Hiron M; Hellot MF; Salier JP
Mol Carcinog; 2003 Mar; 36(3):130-41. PubMed ID: 12619035
[TBL] [Abstract][Full Text] [Related]
9. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
10. Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma.
Yang EB; Qin LL; Zhao YN; Zhang K; Chow P
Int J Mol Med; 2003 Jun; 11(6):773-8. PubMed ID: 12736721
[TBL] [Abstract][Full Text] [Related]
11. Missense mutation of the MET gene detected in human glioma.
Moon YW; Weil RJ; Pack SD; Park WS; Pak E; Pham T; Karkera JD; Kim HK; Vortmeyer AO; Fuller BG; Zhuang Z
Mod Pathol; 2000 Sep; 13(9):973-7. PubMed ID: 11007037
[TBL] [Abstract][Full Text] [Related]
12. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions.
Grigioni WF; Fiorentino M; D'Errico A; Ponzetto A; Crepaldi T; Prat M; Comoglio PM
Hepatology; 1995 Jun; 21(6):1543-6. PubMed ID: 7768498
[TBL] [Abstract][Full Text] [Related]
14. [p53 gene mutation in hepatocellular carcinoma].
Jiang W; Lu Q; Pan G
Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
[TBL] [Abstract][Full Text] [Related]
15. Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride.
Weihrauch M; Benicke M; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
Br J Cancer; 2001 Apr; 84(7):982-9. PubMed ID: 11286481
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of c-myc gene amplification, MTS1/p16 gene alternation, and HBV infection in human hepatocellular carcinoma].
Zhang J; Wang K; Cong S; Qiu F; Wang X; Wang P
Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):294-6. PubMed ID: 11676877
[TBL] [Abstract][Full Text] [Related]
17. The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma.
Yang DH; Huang W; Cui J; Shu JC; Tang SH; Zhang WJ; Liang JH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):86-9. PubMed ID: 14969845
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the E2-PePHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma.
Bagaglio S; De Mitri MS; Lodrini S; Paties C; Cassini R; Bianchi G; Bernardi M; Lazzarin A; Morsica G
J Viral Hepat; 2005 May; 12(3):243-50. PubMed ID: 15850464
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
